Evidence map›Paper›PMID 27455990›Full record

ArticleEndocrine2016

SF-1 deficiency causes lipid accumulation in Leydig cells via suppression of STAR and CYP11A1.

Megumi Hatano, Toshiro Migita, Tomokazu Ohishi, Yuichi Shima, Yoshihiro Ogawa, Ken-Ichirou Morohashi, Yukihiro Hasegawa, Futoshi Shibasaki

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Role ofCurrent issues in molecular biology · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Sertoli cell-derived exosome-mediated transfer of miR-145-5p inhibits Leydig cell steroidogenesis by targeting steroidogenic factor 1.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  11. Article
  12. Role of Constitutive STAR in Leydig Cells.International journal of molecular sciences · 2021
    Article
  13. Article
  14. Article
  15. Journal of the Endocrine Society · 2020
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Megumi HatanoDepartment of Molecular Medical Research, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Toshiro MigitaDepartment of Molecular Medical Research, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan. toshiro.migita@gmail.com.
Tomokazu OhishiDepartment of Molecular Medical Research, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Yuichi ShimaDepartment of Molecular Biology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yoshihiro OgawaDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Ken-Ichirou MorohashiDepartment of Molecular Biology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Yukihiro HasegawaDivision of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Tokyo, Japan.
Futoshi ShibasakiDepartment of Molecular Medical Research, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Kyushu University · JPTokyo Medical and Dental University · JPTokyo Metropolitan Institute of Medical Science · JPMicrobial Chemistry Research Foundation · JPTokyo Metropolitan Children's Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic mutations of steroidogenic factor 1 (also known as Ad4BP or Nr5a1) have increasingly been reported in patients with 46,XY disorders of sex development (46,XY disorders of sex development). However, because the phenotype of 46,XY disorders of sex development with a steroidogenic factor 1 mutation is wide-ranging, its precise diagnosis remains a clinical problem. We previously reported the frequent occurrence of lipid accumulation in Leydig cells among patients with 46,XY disorders of sex development with a steroidogenic factor 1 mutation, an observation also reported by other authors. To address the mechanism of lipid accumulation in this disease, we examined the effects of steroidogenic factor 1 deficiency on downstream targets of steroidogenic factor 1 in in vitro and in vivo. We found that lipid accumulation in Leydig cells was enhanced after puberty in heterozygous steroidogenic factor 1 knockout mice compared with wild-type mice, and was accompanied by a significant decrease in steroidogenic acute regulatory protein and CYP11A1 expression. In mouse Leydig cell lines, steroidogenic factor 1 knockdown induced a remarkable accumulation of neutral lipids and cholesterol with reduced androgen levels. Steroidogenic factor 1 knockdown reduced the expression of steroidogenic acute regulatory protein and CYP11A1, both of which are transcriptional targets of steroidogenic factor 1 and key molecules for steroidogenesis from cholesterol in the mitochondria. Knockdown of either steroidogenic acute regulatory protein or CYP11A1 also induced lipid accumulation, and knockdown of both had an additive effect. Our data suggested that lipid accumulation in the Leydig cells of the 46,XY disorders of sex development phenotype with a steroidogenic factor 1 mutation is due, at least in part, to the suppression of steroidogenic acute regulatory protein and CYP11A1, and a resulting increase in unmetabolized cholesterol.

Indexed as

AnimalsCholesterolCholesterol Side-Chain Cleavage EnzymeLeydig CellsLipid MetabolismMaleMiceMice, KnockoutPhosphoproteinsSteroidogenic Acute Regulatory ProteinSteroidogenic Factor 1CholesterolCholesterol Side-Chain Cleavage EnzymePhosphoproteinsSteroidogenic Acute Regulatory ProteinSteroidogenic Factor 1steroidogenic factor 1, mouseLeydigLipidSF-1

Identifiers

PMID27455990
OpenAlexW2490084000

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.